51 related articles for article (PubMed ID: 32367200)
21. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma.
Baek SY; Hwang UW; Suk HY; Kim YW
Biomolecules; 2020 May; 10(5):. PubMed ID: 32375410
[TBL] [Abstract][Full Text] [Related]
22. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
[TBL] [Abstract][Full Text] [Related]
23. Exenatide induces autophagy and prevents the cell regrowth in HepG2 cells.
Krause GC; Lima KG; Levorse V; Haute GV; Gassen RB; Garcia MC; Pedrazza L; Donadio MVF; Luft C; de Oliveira JR
EXCLI J; 2019; 18():540-548. PubMed ID: 31611738
[TBL] [Abstract][Full Text] [Related]
24. A global view of hepatocellular carcinoma: trends, risk, prevention and management.
Yang JD; Hainaut P; Gores GJ; Amadou A; Plymoth A; Roberts LR
Nat Rev Gastroenterol Hepatol; 2019 Oct; 16(10):589-604. PubMed ID: 31439937
[TBL] [Abstract][Full Text] [Related]
25. Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy.
Mills CC; Kolb EA; Sampson VB
Cancer Res; 2018 Jan; 78(2):320-325. PubMed ID: 29311160
[TBL] [Abstract][Full Text] [Related]
26. The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review.
Haque I; Subramanian A; Huang CH; Godwin AK; Van Veldhuizen PJ; Banerjee S; Banerjee SK
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29301217
[TBL] [Abstract][Full Text] [Related]
27. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.
Khemlina G; Ikeda S; Kurzrock R
Mol Cancer; 2017 Aug; 16(1):149. PubMed ID: 28854942
[TBL] [Abstract][Full Text] [Related]
28. Liraglutide, a glucagon-like peptide-1 analog, induce autophagy and senescence in HepG2 cells.
Krause GC; Lima KG; Dias HB; da Silva EFG; Haute GV; Basso BS; Gassen RB; Marczak ES; Nunes RSB; de Oliveira JR
Eur J Pharmacol; 2017 Aug; 809():32-41. PubMed ID: 28501576
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle proteins as promising targets in cancer therapy.
Otto T; Sicinski P
Nat Rev Cancer; 2017 Jan; 17(2):93-115. PubMed ID: 28127048
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.
Sapisochin G; Bruix J
Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):203-217. PubMed ID: 28053342
[TBL] [Abstract][Full Text] [Related]
31. Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.
Sampson VB; Vetter NS; Zhang W; Patil PU; Mason RW; George E; Gorlick R; Kolb EA
Oncotarget; 2016 Dec; 7(52):86594-86607. PubMed ID: 27863409
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin and fructose-1,6-bisphosphate reduce the HEPG2 cell proliferation via increase of free radicals and apoptosis.
da Silva EF; Krause GC; Lima KG; Haute GV; Pedrazza L; Mesquita FC; Basso BS; Velasquez AC; Nunes FB; de Oliveira JR
Oncol Rep; 2016 Nov; 36(5):2647-2652. PubMed ID: 27665945
[TBL] [Abstract][Full Text] [Related]
33. Targeting WEE1 Kinase in Cancer.
Matheson CJ; Backos DS; Reigan P
Trends Pharmacol Sci; 2016 Oct; 37(10):872-881. PubMed ID: 27427153
[TBL] [Abstract][Full Text] [Related]
34. Immunology of hepatocellular carcinoma.
Sachdeva M; Chawla YK; Arora SK
World J Hepatol; 2015 Aug; 7(17):2080-90. PubMed ID: 26301050
[TBL] [Abstract][Full Text] [Related]
35. Guide for diagnosis and treatment of hepatocellular carcinoma.
Attwa MH; El-Etreby SA
World J Hepatol; 2015 Jun; 7(12):1632-51. PubMed ID: 26140083
[TBL] [Abstract][Full Text] [Related]
36. Human uridine phosphorylase-1 inhibitors: a new approach to ameliorate 5-fluorouracil-induced intestinal mucositis.
Renck D; Santos AA; Machado P; Petersen GO; Lopes TG; Santos DS; Campos MM; Basso LA
Invest New Drugs; 2014 Dec; 32(6):1301-7. PubMed ID: 25052233
[TBL] [Abstract][Full Text] [Related]
37. Liver transplantation for hepatocellular carcinoma.
Byam J; Renz J; Millis JM
Hepatobiliary Surg Nutr; 2013 Feb; 2(1):22-30. PubMed ID: 24570911
[TBL] [Abstract][Full Text] [Related]
38. Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on 5-fluorouracil cytotoxicity.
Renck D; Machado P; Souto AA; Rosado LA; Erig T; Campos MM; Farias CB; Roesler R; Timmers LF; de Souza ON; Santos DS; Basso LA
J Med Chem; 2013 Nov; 56(21):8892-902. PubMed ID: 24131420
[TBL] [Abstract][Full Text] [Related]
39. Development of monoclonal antibodies against the abnormal prion protein isoform (PrP(res)) associated with chronic wasting disease (CWD).
Jeong HJ; Lee NH; Lee JB; Park SY; Song CS; Seo KH; Kim DW; Kim YS; Choi IS
J Vet Sci; 2012 Dec; 13(4):429-32. PubMed ID: 23271186
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
